Beyond lifestyle modification: the role of GLP-1 receptor agonists in treating pediatric obesity.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Beyond lifestyle modification: the role of GLP-1 receptor agonists in treating pediatric obesity.
- Published In:
- Frontiers in pediatrics, 13, 1684485 (2025)
- Authors:
- Wen, Hua
- Database ID:
- RPEP-14118
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-14118APA
Wen, Hua. (2025). Beyond lifestyle modification: the role of GLP-1 receptor agonists in treating pediatric obesity.. Frontiers in pediatrics, 13, 1684485. https://doi.org/10.3389/fped.2025.1684485
MLA
Wen, Hua. "Beyond lifestyle modification: the role of GLP-1 receptor agonists in treating pediatric obesity.." Frontiers in pediatrics, 2025. https://doi.org/10.3389/fped.2025.1684485
RethinkPeptides
RethinkPeptides Research Database. "Beyond lifestyle modification: the role of GLP-1 receptor ag..." RPEP-14118. Retrieved from https://rethinkpeptides.com/research/wen-2025-beyond-lifestyle-modification-the
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.